TYLENOL W Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tylenol W, and what generic alternatives are available?
Tylenol W is a drug marketed by Ortho Mcneil Pharm, Janssen Pharms, and Kenvue Brands. and is included in six NDAs.
The generic ingredient in TYLENOL W is acetaminophen; naproxen sodium. There are two drug master file entries for this compound. Additional details are available on the acetaminophen; naproxen sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TYLENOL W?
- What are the global sales for TYLENOL W?
- What is Average Wholesale Price for TYLENOL W?
Summary for TYLENOL W
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 6 |
| DailyMed Link: | TYLENOL W at DailyMed |
US Patents and Regulatory Information for TYLENOL W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | TYLENOL W/ CODEINE | acetaminophen; codeine phosphate | SOLUTION;ORAL | 085057-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Janssen Pharms | TYLENOL W/ CODEINE NO. 2 | acetaminophen; codeine phosphate | TABLET;ORAL | 085055-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ortho Mcneil Pharm | TYLENOL W/ CODEINE | acetaminophen; codeine phosphate | TABLET;ORAL | 085056-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
